Semaglutide Shows Promise for Long-Term Weight Loss, Dosage and Duration Key
• A recent study indicates that semaglutide, known as Ozempic and Wegovy, is effective for long-term weight loss in obese patients.
• Higher dosages and consistent use of semaglutide for over 90 days correlated with more successful weight loss outcomes.
• Research suggests semaglutide increases metabolic activity, challenging the belief that it solely reduces food intake.
• The FDA has declared a shortage of Wegovy due to increased demand, highlighting the drug's popularity and impact.
© Copyright 2025. All Rights Reserved by MedPath